MCL1 and melanoma: These findings highlight the necessity of inhibiting Mcl-1 to induce apoptosis in melanoma cells, and suggest that combinations of BH3 mimetics and inhibitors against other survival pathways may minimise anti-apoptotic effects, thus enhancing induction of apoptosis.